Johnson & Johnson reports first-quarter sales above expectations

Johnson & Johnson reported first-quarter revenue above analysts’ estimates on Tuesday, driven partly by demand for its Stelara treatment for psoriasis and Crohn’s disease and cancer drugs Darzalex and Imbruvica.

…read more

Source:: Reuters – Business News